(571) 447-5500
Dietary Supplement Finished Product Testing and Specifications

Dietary Supplement Finished Product Testing and Specifications

The FDA requires that dietary supplement manufactures establish finished product specifications and test to ensure the specifications are met. However, the process of implementing this requirement is not always straightforward. What tests need to be included? Does every lot have to be tested? What if there is not a scientifically valid method available? This webinar will answer those questions and explain how to be compliant with the specification requirement for finished dietary supplement products.

Food Safety Foundation: Developing a Risk-Based Supplier Approval Program

Food Safety Foundation: Developing a Risk-Based Supplier Approval Program

In this webinar, we will review the components of a risk-based supplier approval program to include (1) conducting a risk assessment, (2) conducting supplier verification, (3) ensuring adequate and proper documentation, and (4) implementing continuous improvement. Additionally, we will review supplier approval program requirements of the FDA and USDA and how these regulations compare some common 3rd party certification audit standards.

Medical Device QMSR (ISO 13485)

Medical Device QMSR (ISO 13485)

This webinar will highlight the major changes to the regulations and give an overview of how the regulations have updated. Also covered are implementation of the new final rule, and what steps to take to best prepare for the start of enforcement by the FDA.

Health Canada

Health Canada

Interested in doing business of health products in Canada? This free webinar provides an overview of the Canadian regulation on natural health products and how EAS can assist companies with the diverse requirements of Health Canada.

How to Respond to an FDA Inspection (483)

How to Respond to an FDA Inspection (483)

Now that the FDA has issued your firm a 483 or Warning Letter, what to do next? This webinar will cover the expectations and requirements of the FDA for responding to inspectional findings, best practices, and tips for creating a comprehensive response, including corrective and preventive actions taken and planned to address the observations.